GLP-1 receptor agonists mimic this hormone to produce weight loss and blood sugar control
Patients taking Wegovy should never drastically reduce calories without professional guidance, as the medication itself significantly reduces appetite, and combining this with severe restriction may lead to inadequate nutrient intake and adverse effects such as fatigue, dizziness, or hair loss (which can occur with rapid weight loss)
Some patients achieve therapeutic benefit at lower doses, while others require dose escalation for metabolic effect
Punitive damages are likely to be a factor
Because skin substitutes generally do not have National Drug Codes, CMS has operationalized this process for skin substitutes by allowing manufacturers of skin substitutes to self-select an Alternate ID to distinguish between different skin substitute products
The GLP-1 agonist was created with the purpose of becoming a long-lasting alternative diabetes therapy